Mydecine Innovations Group Inc.
MYCOF
$0.0065
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.46% | 78.63% | 84.75% | -3.31% | -7.49% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -92.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.93% | -85.85% | -93.38% | 479.76% | 414.75% |
| Change in Net Operating Assets | -103.14% | -66.41% | -54.73% | -19.74% | -19.56% |
| Cash from Operations | 97.11% | 98.99% | 99.08% | 93.11% | 91.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Issued | -- | -- | -- | 7.11% | 7.11% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -94.07% | -94.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -91.39% | -91.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.46% | -224.32% | -245.18% | 155.32% | 37.29% |